Clarus IV-C, L.P.'s Net Worth
$2.41 Million
Who is Clarus IV-C, L.P.?
Clarus IV-C, L.P. has an estimated net worth of $2.41 Million. This is based on reported shares across multiple companies, which include Talaris Therapeutics, Inc., and Galera Therapeutics, Inc..
SEC CIK
Clarus IV-C, L.P.'s CIK is 0001700718
Past Insider Trading and Trends
2021 was Clarus IV-C, L.P.'s most active year for acquiring shares with 20 total transactions. Clarus IV-C, L.P.'s most active month to acquire stocks was the month of April. 2021 was Clarus IV-C, L.P.'s most active year for disposing of shares, totalling 13 transactions. Clarus IV-C, L.P.'s most active month to dispose stocks was the month of April. 2019 saw Clarus IV-C, L.P. paying a total of $3,000,000.00 for 1,678,984 shares, this is the most they've acquired in one year. In 2021 Clarus IV-C, L.P. cashed out on 43,117,391 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Talaris Therapeutics, Inc. (TRML) Snapshot price: $36.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +75.24% | 8.09M |
$17.00 | $510,000.00 | 18.84M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1729
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +117.49% | 1.68M |
$12.00 | $3,000,000.00 | 3.11M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||